Immunodiagnostic Systems Hldgs PLC Additional Listing to Correct Discrepancy (6449A)
June 03 2021 - 2:00AM
UK Regulatory
TIDMIDH
RNS Number : 6449A
Immunodiagnostic Systems Hldgs PLC
03 June 2021
3 June 2021
Immunodiagnostic Systems Holdings plc
Additional Listing to Correct Historical Discrepancy
Immunodiagnostic Systems Holdings plc ("IDS" or the "Company")
(LSE: IDH) today announces that an application has been made to the
London Stock Exchange for the admission of 102,674 ordinary shares
of 10p each ('Ordinary Shares') in IDS in order to correct a
historical discrepancy between its issued share capital and the
share capital recorded as having been admitted to trading on
AIM.
On 10 May 2010, IDS announced the issue and allotment of 2,674
Ordinary Shares to satisfy an exercise of options and on 29 June
2011 IDS announced the issue and allotment of 100,000 Ordinary
Shares to satisfy an exercise of options. In both cases a listing
application was not submitted due to an administrative oversight
and therefore 102,674 Ordinary Shares were not admitted to trading
on AIM at that time. It is expected that the 102,674 Ordinary
Shares will be admitted to trading on 8 June 2021.
No new Ordinary Shares have been issued or allotted and IDS
confirms that its issued share capital remains unchanged at
28,784,097 Ordinary Shares as at 2 June 2021 (excluding 627,078 IDS
Shares held in treasury).
For further information please contact:
Immunodiagnostic Systems Holdings plc Tel : +44 (0)191 5190660
Paul Martin, Group Finance Director
Peel Hunt LLP Tel : +44 (0)207 418 8900
James Steel
Victoria Erskine
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ALSUUUBRANUNRAR
(END) Dow Jones Newswires
June 03, 2021 02:00 ET (06:00 GMT)
Immunodiagnostic Systems (LSE:IDH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Immunodiagnostic Systems (LSE:IDH)
Historical Stock Chart
From Apr 2023 to Apr 2024